Compare Sunrun Inc (RUN) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sunrun Inc vs GeneDx Holdings Corp — how do they compare? Sunrun Inc trades at $7.64 (market cap $1.83B), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: Sunrun Inc and GeneDx Holdings Corp are close in size by market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Sunrun Inc for 16 Days and GeneDx Holdings Corp for 19 Days on average.
| RUN | WGS | |
|---|---|---|
Market Cap | $1.83B | $2.02B |
Volume | 8,672,852 | 734,640 |
Sector | Energy | Health |
52-Week High | $21.41 | $167.51 |
52-Week Low | $7.59 | $34.51 |
Typical Hold Time | 16 Days | 19 Days |
Enterprise Value | $16.35B | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sunrun (RUN) trades at $7.55, down 0.79% recently, with technical indicators showing bearish momentum despite strong analyst support. The company demonstrates solid profitability with 35.29% gross margins and has beaten earnings expectations for three consecutive quarters. Recent partnerships with Tesla and Voltus highlight strategic positioning in distributed energy, though negative operating cash flow and high debt levels present challenges.
The stock appears fundamentally undervalued with a P/E of 5.16 and P/S of 0.59, while analyst consensus targets $16.33 representing 116% upside potential. However, persistent negative cash flows, high interest expenses, and solar industry headwinds from borrowing costs create significant execution risks that could limit near-term performance despite the attractive valuation.
GeneDx (WGS) trades at $68.09, down 0.64% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue beating expectations but negative profitability metrics, including a -23.4% net income margin. Recent news highlights product launches and industry recognition, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth opportunity in genomic testing with strong analyst support, but faces significant execution risks from persistent losses and high valuation multiples. Key catalysts include continued revenue growth and path to profitability, while risks include competitive pressures and cash flow challenges from negative operating cash flow in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
